Burning Rock Biotech LimitedBurning Rock Biotech LimitedBurning Rock Biotech Limited

Burning Rock Biotech Limited

No trades
No trades

Compare with Burning Rock Biotech Limited


Market capitalization
‪153.67 M‬ USD
−0.91 USD
‪−7.70 M‬ USD
‪75.06 M‬ USD
‪8.76 M‬
Beta (1Y)
3.22
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Company info


CEO
Yu Sheng Han
Headquarters
Guangzhou
Founded
2014
IPO date
Jun 12, 2020
ISIN
US12233L2060
CUSIP
12233L206
FIGI
BBG00V1JWDY7
Identifiers
ISIN US12233L2060
Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The firm operates through the following segments: Central Laboratory Business, In-Hospital Business and Pharma Research and Development Services. Its products and clinical applications include companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction and tumor susceptibility tests. The company was founded by Yu Sheng Han in January 2014 and is headquartered in Guangzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.